VitalCare Diabetes Treatment Centers
VitalCare Diabetes Treatment Centers
BREAKTHROUGH MEDICAL TECHNOLOGY
VitalCare Diabetes Treatment Centers are leading the way to a healthier life for diabeticsÛ
Understanding diabetes and the role of insulin
Diabetes is a common condition in which the amount of glucose (sugar) in the blood is too high because the body is unable to use it properly. This is because the body•s method of converting glucose into energy as the Ïprimary fuelÓ for cellular metabolism is not working as it should. In fact, the cells compensate by switching to Ïfat metabolismÓ as the primary cellular fuel, since they canÌt use glucose due to insulin insufficiency or the liver's desensitization to insulin. Diabetes can lead to serious complications, such as heart disease, strokes, amputations, eye and kidney damage, and premature death. The hormone, insulin, carefully controls the amount of glucose in the blood. Insulin is produced by the pancreas and triggers enzymatic processes within the liver which allows glucose to enter the cells where it is used as the Ïprimary fuelÓ source throughout the body.
Many people with Type 1 and Type 2 diabetes are dependent on insulin injections and are in jeopardy of persistent fluctuations of their blood sugar. Our micro-pulsed insulin treatment has been developed, tested and shown to be extremely effective. It is without any documented side effects or complications with over 100,000 treatments given to date. This proprietary treatment protocol is precise and only requires one insulin treatment every 7-10 days. VitalCare Technology is working together with its strategic partners to turn this "Medical Miracle" into a diabetic, complication free÷"Reality".
VitalCare's Medically accomplished team is moving this patented and FDA approved technology into the commercial market working with Certified Licensed Healthcare Providers who are delivering Intercellular Activation Therapy or ÏiCAT TherapyÓ in licensed ÏVitalCare Diabetes Treatment CentersÓ. The therapy uses a specially designed micro-dose pulsatile insulin pump that delivers micro-doses of insulin, identical to the way a normal pancreas secretes insulin into the blood stream delivering insulin to the liver during and after a meal, while Ïreal-timeÓ measurements of the patientÌs blood sugar level and metabolic rate, using end-tidal CO2 measurements are obtained from the patient using a metabolic cart. This data is inputted into the computer adjusting the insulin dosage. The metabolic cart uses state-of-the-art technology to measure exhaled CO2 thru a small mouth piece. The result of ÏiCATÓ treatment is the ÏreactivationÓ of the patientÌs metabolism as seen with normalization of liver enzyme function which returns the body cells back to utilizing glucose, to optimize cellular metabolism. The iCAT Treatment leads to the stabilization and in many cases a reversal of secondary complications seen in Type 2 diabetes. Stabilization of Type 1 diabetes is seen, as well. No other technology or protocol has demonstrated this same level of success in clinical trials as iCAT Therapy.
California Office:
310 McArthur Way, Ste. B
Upland, CA 91786-5630
1.877.NO-DIABETES
Fax 909.931.1780
